Advanced Portfolio Management LLC purchased a new position in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor purchased 10,000 shares of the healthcare conglomerate's stock, valued at approximately $5,059,000. UnitedHealth Group comprises 5.9% of Advanced Portfolio Management LLC's investment portfolio, making the stock its 3rd biggest position.
Other institutional investors and hedge funds have also modified their holdings of the company. Alaethes Wealth LLC boosted its position in UnitedHealth Group by 0.7% during the fourth quarter. Alaethes Wealth LLC now owns 4,647 shares of the healthcare conglomerate's stock worth $2,351,000 after purchasing an additional 33 shares during the period. 1248 Management LLC acquired a new position in UnitedHealth Group during the 4th quarter worth $1,527,000. 360 Financial Inc. grew its position in shares of UnitedHealth Group by 29.8% in the fourth quarter. 360 Financial Inc. now owns 1,088 shares of the healthcare conglomerate's stock valued at $550,000 after purchasing an additional 250 shares during the last quarter. 4WEALTH Advisors Inc. acquired a new position in shares of UnitedHealth Group during the 4th quarter worth about $319,000. Finally, Gallagher Fiduciary Advisors LLC increased its position in UnitedHealth Group by 22.2% in the 4th quarter. Gallagher Fiduciary Advisors LLC now owns 876 shares of the healthcare conglomerate's stock worth $443,000 after buying an additional 159 shares during the period. Institutional investors and hedge funds own 87.86% of the company's stock.
Wall Street Analyst Weigh In
A number of equities analysts recently issued reports on the stock. KeyCorp dropped their target price on shares of UnitedHealth Group from $650.00 to $575.00 and set an "overweight" rating on the stock in a research report on Monday, April 21st. Barclays decreased their price objective on UnitedHealth Group from $642.00 to $560.00 and set an "overweight" rating on the stock in a report on Monday, April 21st. Cantor Fitzgerald reiterated an "overweight" rating and set a $700.00 price target on shares of UnitedHealth Group in a research note on Friday, January 17th. Oppenheimer reduced their price objective on shares of UnitedHealth Group from $640.00 to $600.00 and set an "outperform" rating for the company in a report on Monday, April 21st. Finally, HSBC restated a "hold" rating and set a $490.00 price target on shares of UnitedHealth Group in a research note on Tuesday, April 22nd. Three investment analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and three have issued a strong buy rating to the company. Based on data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Buy" and a consensus target price of $596.86.
Get Our Latest Stock Analysis on UnitedHealth Group
UnitedHealth Group Stock Down 0.5 %
Shares of UNH opened at $398.72 on Friday. The firm has a market capitalization of $362.92 billion, a price-to-earnings ratio of 25.72, a PEG ratio of 1.37 and a beta of 0.61. UnitedHealth Group Incorporated has a 52 week low of $393.11 and a 52 week high of $630.73. The company has a debt-to-equity ratio of 0.74, a quick ratio of 0.91 and a current ratio of 0.83. The business's fifty day moving average price is $495.85 and its two-hundred day moving average price is $528.74.
UnitedHealth Group (NYSE:UNH - Get Free Report) last released its earnings results on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share (EPS) for the quarter, missing analysts' consensus estimates of $7.29 by ($0.09). UnitedHealth Group had a net margin of 3.60% and a return on equity of 26.69%. The business had revenue of $109.58 billion for the quarter, compared to analyst estimates of $111.56 billion. During the same quarter in the previous year, the company posted $6.91 earnings per share. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.
UnitedHealth Group Announces Dividend
The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were paid a $2.10 dividend. The ex-dividend date was Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 2.11%. UnitedHealth Group's dividend payout ratio (DPR) is presently 35.18%.
UnitedHealth Group Company Profile
(
Free Report)
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.
See Also
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.
Before you consider UnitedHealth Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and UnitedHealth Group wasn't on the list.
While UnitedHealth Group currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Enter your email address and below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.